Unilife -UNIS

633 Lowther Road

Lewisberry, PA 17339

US Toll-Free: 1.800.324.7674

P: 717.938.9323

F: 717.938.9364

info@unilife.com

Shareholder / Analyst Inquiries:

AU Jeff Carter P: + 61.2.8346.6500

US Stuart Fine P: + 1.908.469.1788


Unilife Newsroom Blog

Current Articles | RSS Feed RSS Feed

Unilife (NASDAQ: UNIS) Appoints Christopher Naftzger as General Counsel, Corporate Secretary and Chief Compliance Officer

  
  
  
  
  
  
describe the imageUnilife Corporation, expanded its management team to include Christopher Naftzger as the Company's General Counsel, Corporate Secretary and Chief Compliance Officer. Mr. Naftzger will provide the management team and Board of Directors of Unilife with counsel on all international, legal and government matters as well as corporate finance and SEC regulation.

Prior to joining Unilife, Mr. Naftzger served on the senior management team as assistant general counsel and assistant secretary of Chesapeake Corporation, a global supplier of packaging to the pharmaceutical, healthcare and consumer industries. While at Chesapeake, Mr. Naftzger participated in all Board of Directors and Board Committee meetings as well as coordinated with the global sales team on negotiations for multi-year / multi-product supply contracts with a number of leading pharmaceutical and healthcare companies.

Mr. Naftzger has also served as the senior counsel at Koch Industries, Inc, the second largest privately held company in the U.S. with revenues of approximately $98 billion in 2008, and as a partner at Blank Rome LLP, a full service international law and government affairs firm. He holds a juris doctorate from Willamette University College of Law in Oregon, and a bachelor's degree from Hampden-Sydney College in Virginia.

Mr. Alan Shortall, Chief Executive Officer of Unilife, said, "We are pleased to add Chris to our executive team. We believe his extensive knowledge and experience as a lawyer and corporate secretary will be an asset as we continue to expand the Company, and build commercial relationships with a number of pharmaceutical customers. His appointment should also help to reduce outside legal costs in areas such as SEC compliance and contract negotiations."

Comments

Currently, there are no comments. Be the first to post one!
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics

Unilife Landing Page

unilife logo